FindTrial
Sign In

Clonidine and hemodynamics and sedation

Comparative study of the effect of clonidine with placebo before surgery on hemodynamics and sedation of patients in stereotaxic surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210614051574N2
Enrollment
72
Registered
2021-07-12
Start date
2021-08-10
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor. Malignant neoplasm of brain stem

Interventions

Intervention 1: Intervention group: Patients in this group receive clonidine in a dose of 0.2 mg, 2 hours before the operation. Blood pressure and sedation of patients in this group will be measured i

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 20 to 65 years Conscious consent to enter the study Candidate for stereotaxic surgery Lack of drug sensitivity

Exclusion criteria

Exclusion criteria: Changing the surgical plan for any reason Changing the anesthesia plan for any reason

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: In minute one, three, five, ten, fifteen after the intervention and at the time of entering the recovery and every fifteen minutes in the recovery. Method of measurement: Measured by barometer.;Sedation. Timepoint: In minute one, three, five, ten, fifteen after the intervention and at the time of entering the recovery and every fifteen minutes in the recovery. Method of measurement: Richmond criteria.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Masoudifar

Esfahan University of Medical Sciences

parsa.alinezhad85@gmail.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026